Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8KLV8

Entry ID Method Resolution Chain Position Source
AF-Q8KLV8-F1 Predicted AlphaFoldDB

No variants for Q8KLV8

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q8KLV8

2 associated diseases with Q8KLV8

[MIM: 158590]: Neuronopathy, distal hereditary motor, 2A (HMN2A)

A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. {ECO:0000269|PubMed:15122253, ECO:0000269|PubMed:28144995}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 608673]: Charcot-Marie-Tooth disease 2L (CMT2L)

An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology

Without disease ID
  • A neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. {ECO:0000269|PubMed:15122253, ECO:0000269|PubMed:28144995}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology

3 regional properties for Q8KLV8

Type Name Position InterPro Accession
conserved_site 14-3-3 protein, conserved site 45 - 55 IPR023409-1
conserved_site 14-3-3 protein, conserved site 217 - 236 IPR023409-2
domain 14-3-3 domain 7 - 248 IPR023410

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
GTP binding Binding to GTP, guanosine triphosphate.

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MRLIIVSGRS GSGKSTALNV LEDNGFYCID NLPAGLLPEL AERALLHTEL LHPQVAVSID
70 80 90 100 110 120
ARNLPSQLKR FPELLEEVRA RHIQCDVLYL DADDETLLKR FSETRRRHPL TNESRSLAEA
130 140 150 160 170 180
IRDEELLLAA IIDHADLKID TTHLNLYQLR DMLKLRLLNK PEPGTAFLIE SFGFKRGMPV
190 200 210 220 230 240
DADLVFDVRC LPNPYWKAEL RDFSGLDQPV IDYLAAQPDV EEMFQDIHAY LNKWLPRFAA
250 260 270 280
SNRAYVTIAI GCTGGHHRSV YLAERLGLAL KEPLKNLQVR HRDLA